Novel activators of dendritic cells as fundamental tools in immunotherapy

Bibliography

• JENNER E: An inquiry into the causes and effects of the variolae vaccinae, (Ed.) Low, London, (1798).
   Google Scholar
• SMYTH MJ, GODFREY DI, TRAPANI J. A: A fresh look at tumor immunosurveillance and immunotherapy: Nat. Immunol. (2001) 2:293–299.
   Google Scholar
• PIERRE P, TURLEY SJ, GATTI E, et al.: Developmental regulation of MHC class II transport in mouse dendritic cells. Nature (1997) 388:787–792.
   Google Scholar
• BANCHEREAU J., STEINMAN RM: Dendritic cells and the control of immunity. Nature (1998) 392:245–252.
   PubMed Web of Science ®Google Scholar
• •• Already a classic of the literature on DCs.
   Google Scholar
• BANCHEREAU J, BRIERE F, CAUX C, et al.: Immunobiology of dendritic cells. Ann. Rev. Immunol. (2000) 18:767–811.
   PubMed Web of Science ®Google Scholar
• ••A complete update on DCs.
   Google Scholar
• SALLUSTO F, CELLA M, DANIELI C, et al.: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. (1995)182:389–400.
   Google Scholar
• DHODAPKAR MV, STEINMAN RM, KRASOVSKY Jet al.: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. (2001)1. Exp. Med. 193: 233–238.
   Google Scholar
• LASSILA O, VAINIO O, MATZINGER P: Can B cells turn on virgin T cells? Nature (1988) 334:253–255.
   PubMed Web of Science ®Google Scholar
• CELLA M, SALLUSTO F,LANZAVECCHIA A: Origin, maturation and antigen presenting function of dendritic cells. Curr .0pin. Immunol. (1997) 9:10–16.
   Google Scholar
• NOURI-SHIRAZI M, BANCHEREAU J, FAY et al.: Dendritic cell based tumor vaccines. Immunol. Lett. (2000) 74:5–10.
   PubMed Web of Science ®Google Scholar
• FONG L, ENGLEMAN EG: Dendritic cells in cancer immunotherapy. Ann. Rev. Immunol. (2000) 18:245–273.
   PubMed Web of Science ®Google Scholar
• GALLUCCI S, MATZINGER P: Danger signals: SOS to the immune system. Cum Opin. Immunol. (2001) 13:114–119.
   PubMed Web of Science ®Google Scholar
• ADEREM A., ULEVITCH R J: Toll-like receptors in the induction of the innate immune response. Nature (2000) 406:782–787.
   PubMed Web of Science ®Google Scholar
• •Nice review on exogenous danger signals and their receptors.
   Google Scholar
• JANEWAY CA, Jr: The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today (1992) 13:11–16.
   PubMedGoogle Scholar
• MEDZHITOV R, JANEWAY CA Jr: How does the immune system distinguish self from nonself? Semin. Immunol. (2000) 12:185-188; discussion 257–344.
   Google Scholar
• MATZINGER P: Tolerance, danger, and the extended family. Ann. Rev. Immunol. (1994) 12:991–1045.
   PubMed Web of Science ®Google Scholar
• MATZINGER P: An innate sense of danger. Semin. Immunol. (1998) 10:399–415.
   PubMed Web of Science ®Google Scholar
• POLTORAK A, HEX, SMIRNOVA I et al.: Defective LPS signaling in C31-1/HeJ and C57BL/10ScCr mice: mutations in T1r4 gene. Science (1998) 282:2085–2088.
   PubMed Web of Science ®Google Scholar
• MEDZHITOV R, PRESTON-HURLBURT P, JANEWAY CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 388:394–397.
   PubMed Web of Science ®Google Scholar
• ALIPRANTIS A, YANG RB, MARK MR et al.: Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science (1999) 285:736–739.
   PubMed Web of Science ®Google Scholar
• ••First report for an apoptotic effect of amember of the Toll-like family of receptors.
   Google Scholar
• DE SMEDT T, PAJAK B, MURAILLE E et al.: Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. (1996) 184:1413–1424.
   PubMed Web of Science ®Google Scholar
• GALLUCCI, S, LOLKEMA M, MATZINGER P: Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. (1999) 5:1249–1255.
   PubMed Web of Science ®Google Scholar
• •This study in mice shows that necrotic primary cells and Type I IFN can activate DCs in vitro and function as adjuvants in vivo.
   Google Scholar
• SAUTER B, ALBERT ML, FRANCISCOL et al.: Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatoty dendritic cells [see comments]." Exp. Med. (2000) 191:423––434.
   Google Scholar
• •This human study shows that necrotic cells can activate DCs in vitro and this function is mostly a property of tumour cells.
   Google Scholar
• SHI Y, ZHENG W, ROCK K Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl Acad Sci. USA. (2000) 97:1459–1465.
   Web of Science ®Google Scholar
• BASU S, BINDER RJ, SUTO R: et al.: Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappaB pathway. Int. Immunol. (2000) 12:1539–1546.
   Google Scholar
• ••The authors show that necrotic but not apoptotic cells can release Hsp-70, Hsp-90, gp-96 and calreticulin and that theseHsps, as purified proteins, as well as the whole necrotic lysates, can induce NFkB translocation and DC maturation.
   Google Scholar
• SINGH-JASUJA H, SCHERER, HILF N et al.: The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. (2000) 30:2211–2215.
   PubMed Web of Science ®Google Scholar
• CHEN W, SYLDATH U, BELLMANN K Human 60-10a heat-shock protein: a danger signal to the innate immune system. J. Immunol. (1999) 162:3212–3219.
   PubMed Web of Science ®Google Scholar
• ASEAA, KRAEFT SK, KURT-JONES EA et al.: HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. (2000) 6:435–442.
   PubMed Web of Science ®Google Scholar
• BASU S, BINDER R J, RAMALINGAM T: CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity.. (2001) 14:303–313.
   PubMed Web of Science ®Google Scholar
• DELNESTE Y, HERBAULT N, GALEA B et al.: Vasoactive intestinal peptide synergizes with TNF-alpha in inducing human dendritic cell maturation. J. Immunol. (1999) 163:3071–3075.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI Y, MATSUMOTO M, KOTANI M et al.: Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J. Immunol. (1999) 163:5989–5993.
   PubMed Web of Science ®Google Scholar
• KODAIRAY, NAIR S K, WRENSHALL L E et al.: Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate./ Immunol. (2000). 165:1599–1604.
   Google Scholar
• WRENSHALL L E, STEVENS R B, CERRA F B et al.: Modulation of macrophage and B cell function by glycosaminoglycans. J. Leukoc. Biol. (1999) 66:391–400.
   Google Scholar
• TERMEER CC, HENNIES J, VOITH U et al.: Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. (2000) 165:1863–1870.
   PubMed Web of Science ®Google Scholar
• CORINTI S, FANALES-BELASIO E, ALBANESI C et al.: Cross-linking of membrane CD43 mediates dendritic cell maturation. J. Immunol. (1999) 162:6331–6336.
   PubMed Web of Science ®Google Scholar
• HAEGEL-KRONENBERGER H, DE LA SALLE H, BOHBOT A et al.: Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells. J Immunol. (1998) 161:3902–3911.
   Google Scholar
• DEAGLIO S, MEHTA K, MALAVASI F: (1998). Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk. Res. (1998) 25:1–12.
   Google Scholar
• BOGDAN C: The function of Type I interferons in antimicrobial immunity. Curr. Opin. Immunol. (2000) 12:419–424.
   PubMed Web of Science ®Google Scholar
• CELLA M, SALTO M, SAKAKIBARA Yet al.: Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. (1999) 189:821–829.
   Google Scholar
• HAVELL EA, BERETICH GR Jr, Carter PB: The mucosal phase of Listeria infection. immunobidogy (1999) 201:164–177.
   PubMed Web of Science ®Google Scholar
• MATTNER J, SCHINDLER H, DIEFENBACH A et al.: Regulation of Type 2 nitric oxide synthase by Type 1 interferons in macrophages infected with Leishmania major. Eur. J. Immunol. (2000) 30:2257–2267.
   PubMed Web of Science ®Google Scholar
• SIEGAL F P, KADOWAK1N, SHODELLM et al.: The nature of the principal Type 1 interferon-producing cells in human blood. Science (1999) 284:1835–1837.
   Google Scholar
• CELLA M, FACCHETTI F,LANZAVECCHIA A et al.: Plasmacytoid dendritic cells activated by influenza virus and CD4OL drive a potent TH1 polarization. Nat. Immunol. (2000) 1:305–310.
   Google Scholar
• LUFT T, PANG K C, THOMAS E et al.: Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. (1998) 161:1947–1953.
   PubMed Web of Science ®Google Scholar
• RADVANYI LG, BANERJEE A, WEIR M et al.: Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells. Scand. J. Immunol. (1999) 50:499–509.
   Google Scholar
• SANTINI SM, LAPENTA C, LOGOZZI S et al.: Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. (2000) 191:1777–1788.
   PubMed Web of Science ®Google Scholar
• REDDY A, SAPP M, FELDMAN M, A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood (1997) 90:3640–3646.
   PubMed Web of Science ®Google Scholar
• CAUX C, MASSACRIER C, VANBERVLIET B et al.: Activation of human dendritic cells through CD40 cross-linking. J. E. Med. (1994) 180:1263–1272.
   PubMed Web of Science ®Google Scholar
• RIDGE JP, DI ROSA F, MATZINGER P: A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (1998) 393:474–478.
   PubMed Web of Science ®Google Scholar
• ANDERSON DM, MARASKOVSKY E, BILLINGSLEY \In. et al.: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature (1997) 390: 175–179.
   Google Scholar
• SIMONET WS, LACEY DL, DUNSTANC et al.: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 89:309–319.
   PubMed Web of Science ®Google Scholar
• JOSIEN R, WONG BR, LI HL et al.: TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. Jimmund. (1999) 162:2562–2568.
   PubMed Web of Science ®Google Scholar
• WONG BR, JOSIEN R, LEE SY et al.: TRANCE (tumor necrosis factor LENFI-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. (1997) 186:2075–2080.
   PubMed Web of Science ®Google Scholar
• CAUX C, AIT-YAHIA S, CHEMIN K et al.: Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. ImmunopathoL (2000) 22:345–369.
   PubMed Web of Science ®Google Scholar
• BAEKKEVOLD ES, YAMANAKA T, PALFRAMAN RT et al.: The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med. (2001) 193:1105–1112.
   PubMed Web of Science ®Google Scholar
• REGNAULT A, LANKAR D,LACABANNE V et al.: Fcgamma receptor-mediated induction of dendritic cellmaturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. (1999) 189:371–380.
   Google Scholar
• SLUPSKY P, KALBAS M, WILLUWEIT A et al.: Activated platelets induce tissue factor expression on human umbelical vein endothelial cells by ligation of CD40. Thromb. Haemost. (1998) 80:1008–1014.
   PubMed Web of Science ®Google Scholar
• RIEDL E, STROBL H, MAJDIC O et al.: TGF-P 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J. Immunol. (1997) 158:1591–1597.
   PubMed Web of Science ®Google Scholar
• STROBL H, KNAPP W: TGF-131 regulation of dendritic cells. Microbes Infect. (1999) 1:1283–1290.
   PubMed Web of Science ®Google Scholar
• BROOKS SP, BERNSTEIN ZP, SCHNEIDER SL et al.: Role of transforming growth factor-PI in the suppressed allostimulatory function of AIDS patients. Aids (1998) 12:481–487.
   PubMed Web of Science ®Google Scholar
• GABRILOVICH DI, CHEN HL, GIRGIS KR et al.: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. (1996) 2:1096–1103.
   PubMed Web of Science ®Google Scholar
• SCHOPPET M, BUBERT A, HUPPERTZ HI: Dendritic cell function is perturbed by Yersinia enterocolitica infection in vitro. Clin. Exp. Immunol. (2000) 122:316–323.
   PubMed Web of Science ®Google Scholar
• JEANNIN P, RENNO T, GOETSCH Let al.: OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat. Immunol. (2000) 1:502–509.
   Google Scholar
• GAGLIARDI M C, SALLUSTO F, MARINARO M et al.: Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. (2000) 30:2394–2403.
   PubMed Web of Science ®Google Scholar
• KRIEG AM: The role of CpG motifs in innate immunity. Curr. Opin. Immunol. (2000) 12:35–43.
   PubMed Web of Science ®Google Scholar
• SPARWASSER T, KOCH ES, VABULAS ES et al.: Bacterial DNA and immunostimulatoty CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. (1998) 28:2045-2054.Though previous papers have shown the effects of CpGs on many immune cells, such as B cells and macrophages, this is the first to present data on DCs.
   Google Scholar
• WEINER G J, LIU H M, WOOLDRIDGE J E et al.:Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc .Natl. Acad. Sci.USA. (1997) 94:1083–1087.
   Google Scholar
• YAMAGUCHI Y, MOTOKI K, UENO H et al.: Enhancing effects of (25,35,4R)-1-0-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol KRN(7000) on antigen- presenting function of antigen-presenting cells and antimetastatic activity of KRN(7000)-pretreated antigen-presenting cells. OncoL Res. (1996) 8:399–407.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI E, MOTOKI K,YAMAGUCHI Yet al.: (1996). Enhancing effects of a-P-monoglycosylceramides on natural killer cell activity. Bioorg Med. Chem. 4: 615–619.
   Google Scholar
• PRAKKEN B, WAUBEN M, GENINI D et al.: Artificial antigen-presenting cells as a tool to exploit the immune 'synapse'. Nat. Med. (2000) 6:1406–1410.
   PubMed Web of Science ®Google Scholar
• RAJALA RV, DATLA RS, MOYANA TN et al.: N-myristoyltransferase. MoL Cell Biochem. (2000) 204:135–155.
   PubMed Web of Science ®Google Scholar
• MEGYERI K, AU WC, ROSZTOCZY I et al.: Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways. MoL Cell Biol. (1995) 15:2207–2218.
   PubMed Web of Science ®Google Scholar